Literature DB >> 16530514

Antisense inhibition of Entamoeba histolytica cysteine proteases inhibits colonic mucus degradation.

Darcym Moncada1, Kathy Keller, Serge Ankri, David Mirelman, Kris Chadee.   

Abstract

BACKGROUND & AIMS: The exact role Entamoeba histolytica cysteine proteases play in overcoming the colonic mucus barrier, as a prerequisite to epithelial cell disruption, is not known. Herein, we determined whether E histolytica trophozoites expressing the antisense transcript to cysteine protease 5 (EhCP5) could degrade colonic mucin and destroy epithelial cells.
METHODS: Cysteine protease-deficient amoebae were generated by antisense inhibition of EhCP5, and assayed for proteolytic activity against [(35)S]cysteine-labeled mucin from LS 174T, and HT-29F Cl.16E cells. Recombinant EhCP5 mucinase activity was also assessed. Disruption of an intact mucus barrier and epithelial cell invasion by amoebae were measured using high mucin producing LS 174T and HT-29 Cl.16E monolayers or Chinese hamster ovary (CHO) cells devoid of a mucus barrier.
RESULTS: Trophozoites with reduced cysteine protease activity were ineffective at degrading [(35)S]cysteine-labeled colonic mucin compared to wild-type amoebae by >60%. However, bioactive recombinant EhCP5 degraded >45% of purified native mucin, which was specifically inhibited by the cysteine proteinase (CP) inhibitor, E-64. Cysteine protease-deficient trophozoites could not overcome a protective intact mucus barrier and disrupt LS 174T or HT-29F Cl.16 cell monolayers; however, they readily adhere to and disrupt CHO monolayers devoid of a mucus barrier.
CONCLUSIONS: These findings unravel a central role for E histolytica CPs as key virulence factors in disrupting an intact mucus barrier in the pathogenesis of intestinal amoebiasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16530514     DOI: 10.1053/j.gastro.2005.11.012

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  29 in total

Review 1.  Role of intestinal mucins in innate host defense mechanisms against pathogens.

Authors:  Poonam Dharmani; Vikas Srivastava; Vanessa Kissoon-Singh; Kris Chadee
Journal:  J Innate Immun       Date:  2008-10-08       Impact factor: 7.349

2.  Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gel.

Authors:  Martin E Lidell; Darcy M Moncada; Kris Chadee; Gunnar C Hansson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

Review 3.  Crosstalk at the initial encounter: interplay between host defense and ameba survival strategies.

Authors:  Xiaoti Guo; Eric Houpt; William A Petri
Journal:  Curr Opin Immunol       Date:  2007-08-16       Impact factor: 7.486

4.  Intriguing parasites and intramembrane proteases.

Authors:  Robert B Rawson
Journal:  Genes Dev       Date:  2008-06-15       Impact factor: 11.361

5.  Entamoeba histolytica cysteine proteinase 5 binds integrin on colonic cells and stimulates NFkappaB-mediated pro-inflammatory responses.

Authors:  Yongzhong Hou; Leanne Mortimer; Kris Chadee
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

6.  Entamoeba histolytica induces intestinal cathelicidins but is resistant to cathelicidin-mediated killing.

Authors:  Eduardo R Cobo; Chen He; Ken Hirata; Grace Hwang; UyenPhuong Tran; Lars Eckmann; Richard L Gallo; Sharon L Reed
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

7.  Control of Entamoeba histolytica adherence involves metallosurface protease 1, an M8 family surface metalloprotease with homology to leishmanolysin.

Authors:  Jose E Teixeira; Adam Sateriale; Kovi E Bessoff; Christopher D Huston
Journal:  Infect Immun       Date:  2012-03-26       Impact factor: 3.441

8.  CD4+ T cells drive goblet cell depletion during Citrobacter rodentium infection.

Authors:  Justin M Chan; Ganive Bhinder; Ho Pan Sham; Natasha Ryz; Tina Huang; Kirk S Bergstrom; Bruce A Vallance
Journal:  Infect Immun       Date:  2013-10-07       Impact factor: 3.441

9.  Use of recombinant Entamoeba histolytica cysteine proteinase 1 to identify a potent inhibitor of amebic invasion in a human colonic model.

Authors:  Samuel G Meléndez-López; Scott Herdman; Ken Hirata; Min-Ho Choi; Youngchool Choe; Charles Craik; Conor R Caffrey; Elisabeth Hansell; Bibiana Chávez-Munguía; Yen Ting Chen; William R Roush; James McKerrow; Lars Eckmann; Jianhua Guo; Samuel L Stanley; Sharon L Reed
Journal:  Eukaryot Cell       Date:  2007-05-18

10.  An ex-vivo human intestinal model to study Entamoeba histolytica pathogenesis.

Authors:  Devendra Bansal; Patrick Ave; Sophie Kerneis; Pascal Frileux; Olivier Boché; Anne Catherine Baglin; Geneviève Dubost; Anne-Sophie Leguern; Marie-Christine Prevost; Rivka Bracha; David Mirelman; Nancy Guillén; Elisabeth Labruyère
Journal:  PLoS Negl Trop Dis       Date:  2009-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.